Učitavanje...
Bacillus Calmette-Guérin (BCG) Therapy for Bladder Cancer: An Update
Physicians treating patients affected by nonmuscle-invasive bladder cancer (NMIBC) have been in shock during the last six years since manufacturing restrictions on the production of the first-option medicine, Mycobacterium bovis Bacillus Calmette-Guérin (BCG), have resulted in worldwide shortages. T...
Spremljeno u:
| Izdano u: | Immunotargets Ther |
|---|---|
| Glavni autori: | , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Dove
2020
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7025668/ https://ncbi.nlm.nih.gov/pubmed/32104666 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/ITT.S202006 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|